of seven

Wellsheet - History and Current Status

Wellsheet organizes clinical information with machine learning to predict and visualize the most relevant information for patient care in a physician-friendly format within the existing electronic health record system. It is a private company that began in 2015, it has 13 employees, their total funding amounts to $3million and the company primarily partners with healthcare providers that struggle with their current EHR.


  • Wellsheet is a private company that was founded on December 28, 2015. Its headquarters is in Newark and has offices in Manhattan and Palo Alto.
  • The founders of the company are Craig Limoli, Justin Larkin and Mike Lytle.
  • The company's vision is to help providers make decisions with a comprehensive view of relevant information, structured precisely for their needs.
  • Its milestones are being accepted to Newark Venture Partners accelerator program on the spring of 2017, being the first company to be accepted as partner with Athenahealth without an existing mutual client, and launching live at a clinic in Hackensack for production use, all done through another EHR partnership.
  • Building off the momentum, WellSheet raised a seed round of financing and launched pilots at major health systems. Their key vendors are REDO Ventures, BioAdvance, Real-Life Innovations and Newark Venture Partners.


  • In November 2017, it closed a $800,000 seed round Funding that came from Real-Life Innovations, Newark Venture Partners, and BioAdvance.


  • Wellsheet is primarily partners with healthcare providers that struggle with the current EHR.
  • There was no data found on Wellsheet's key customers.


  • Wellsheet has 13 known employees on LinkedIn.
  • Employee names are; Craig Limoli Founder and CEO of Wellsheet, Justin Larkin, Satu Barnhill, John Paul Patrizio, Ofer Shapiro, Connor Finnerty, Han Ke, Ali Alobaidi, Johnny Rose, Chuck P and Uri Zilberman.

Research Strategy

We commenced the research process by conducting a thorough scan of the official company's official website. While we found information on the company's vision, we could not find much data concerning the history or revenue, but just a bit on employee data. Thereafter, we searched through the company's social media pages, like Facebook, Twitter, LinkedIn and databases like Crunchbase. We found data on the history of the company, employee names and information on the revenue of the company, but we could not find data on the company's key customers.

We then searched through articles with news on Wellsheet to discover any information on the company's customers. We were able to identify only three customers that the company had partnered with on publicly available sites, but could not find grounds to identify them as Wellsheet's key customers. Wellsheet customers we found are Athenahealth, Hackensack Allergy & Asthma Center, and a neurology clinic in Wyoming. Since this company is a small growing company, most of the data found was minimal.

of seven

Wellsheet - Founder Information

Craig Limoli, Justin Larkin and Mike Lytle share relatively similar biographies, with all three having limited experience as executive leaders, following relatively short careers and a track record of distinguished educational achievement.

Craig Limoli

  • Mr. Limoli has a relatively abbreviated leadership career, with the Wellsheet CEO serving in that capacity since September of 2015.
  • Prior to this executive role, Mr. Limoli was promoted at IBM to the role of Senior Strategy Consultant in the Watson Health & Corporate Strategy group (June of 2014 through May of 2015), after serving as a Strategy Consultant in IBM Global Business Services (August 2012 through May of 2014) as well as an Intern at ConvaTec (June through August of 2011).
  • During his time at IBM, he also served as a Board Member and Future Founders Relationship Manager for IBM Lead (June of 2013 through June of 2014), during which Mr. Limoli facilitated a partnership between the Future Founder Foundation and IBM's Corporate Citizenship Manager of Illinois.
  • His time between these brief professional experiences was punctuated by the graduation from several prestigious academic intuitions, with Mr. Limoli receiving an MBA from the Wharton School with concentrations in health care and entrepreneurial management (2015), a Bachelors in Economics from Princeton University (2012) and a high school diploma from the Pingry School (2008).
  • Mr. Limoli's time in high school and college also highlighted his diverse interests, with the Wellsheet CEO receiving the distinction of Captain of his high school fencing team, a place on varsity fencing at Princeton, and serving in a variety of club-level leadership roles including with his high school robotics club, a college corporate finance group and a college formal services or training agency.
  • Meanwhile, Mr. Limoli has been the subject of a wide variety of interviews and biography discussions, including a recent discussion with publishing trade Medium (December 2018) and fairly recent interviews with healthcare outlets New Jersey Innovation Institute (June of 2017) and MedCity News (October of 2017).
  • Notably, within his most recent published interview with Medium, Mr. Limoli highlighted his interest in entrepreneurship from a young age, as well as how his time at IBM and then Wharton crystallized his focus in the space of healthcare.
  • Additionally, Mr. Limoli actively maintains his professional biography on LinkedIn.

Justin Larkin

  • Similar to Mr. Limoli, Mr. Larkin has a relatively abbreviated leadership career, with the Wellsheet Co-Founder and CMO (November 2015 through July of 2018) graduating from that experience to serve as a Wellsheet Product Adviser in June of 2018, alongside a more recent role in Strategy and Operations at Verily Live Sciences since July of 2018.
  • Prior to these executive experiences, Mr. Larkin also served as a team member at the Hasso Plattner Institute of Design at Stamford (August of 2017 through December of 2017), a team member at Stamford Byers Center for Biodesign (December 2016 through June of 2017) and as an innovation intern at Penn Medicine for several months in 2014.
  • Moreover, Mr. Larking held the role of Research Assistant at Systems Complexity Forum (July 2011 through August 2013), Student Clinical Director at Volunteer Care Clinic (October of 2010 through August of 2013) as well as a Lead Research Assistant (July of 2010 through August of 2013), Head Histology Teaching Assistant (January of 2010 through July of 2013) and Project and Design Specialist (October of 2007 through July of 2013) at Brigham Young University.
  • Meanwhile, these shorter professional experiences and internships were often completed in parallel with distinguished academic achievement, including his most recent receipt of an MBA from Stamford, a Doctor of Medicine from the University of Pennsylvania and Bachelors degrees in physiology and developmental biology as well as Portuguese from Brigham Young University.
  • Notably, while at Brigham Young University, Mr. Larkin also received the recognition of Magna Cum Laude.
  • Additionally, Mr. Larkin has a variety of personal interests, including a strong volunteer track record in the areas of public service and religion, as well as leadership and participation in several healthcare and technology clubs.
  • In terms of interviews or public biographies, Mr. Larkin gave a widely publicized January of 2018 podcast interview with the Penn HealthX Podcast, during which he thoroughly discussed his biography from college to early 2018.
  • Additionally, Mr. Larkin actively maintains his professional biography on LinkedIn.

Mike Lytle

  • Of the three Wellsheet founders, Mr. Lytle has the least leadership experience, with the Wellsheet Chief Product Officer and Co-Founder serving in that capacity between September of 2015 and June of 2017.
  • More recently, Mr. Lytle has served as Product Manager at Fitbit (June of 2018 through present) and Product Manager Intern at Nike (May of 2017 through August of 2017).
  • Prior to co-founding Wellsheet, Mr. Lytle also gained a wide variety of business and healthcare experience as a Strategy and Operations Consultant at Deloitte (August of 2011 through April of 2015), a Business Productivity Analyst at EEWS (June of 2006 through August of 2008) as well as through several internships and short-term engagements at Smart Design (2016), Sense Health (2015), Capital One (2010) and Drop.io (2009).
  • Similar to his co-founders, Mr. Lytle also has a strong academic track record, including an MBA from the Wharton School (2017), a Masters in Integrated Product Design from the University of Pennsylvania (2018), a Bachelors in Economics from Rice University (2011) a full year study abroad experience with the London School of Economics and Political Science (2011) and a high school diploma from Emmaus High School (2007).
  • During his education, Mr. Lytle also demonstrated his personal interest in innovation and design as the Co-President of Penn's Innovation and Design Club, his focus on the environment while serving as Chair of the Martel College Environmental Committee at Rice and his talent as volleyball player in both high school and college.
  • Meanwhile, Mr. Lytle's publicly available interviews or biographies are largely limited to his LinkedIn and AngelList profiles, and highlight other interests such as marathon running.

Research Strategy

Please note, for the purpose of this analysis, it was deemed reasonable and appropriate to provide links to interviews published in 2017 for Craig Limoli, given the lack of more recent published interviews for this key stakeholder in 2018 and 2019. Specifically, given the relative recency of 2017, as well as the fact that these interviews took place during the subjects' time at Wellsheet, it seemed that providing this additional context for reference as desired would be considered helpful and appropriate.
of seven

Wellsheet - Competitors

IBM, Juxly Timeline, EvidenceCare, Caden, HealthDecision, and HealthRevival are all direct competitors of Wellsheet. These companies provide clinical decision support that improves clinician workflow.


  • The website for IBM Watson Health can be found here.
  • IBM Watson Health is a platform that gives the ability to evaluate and improve the effectiveness of clinical operation, increase efficiency while lowering operational costs, and streamline patient care processes by reducing physician variation. IBM Watson Health does so by analyzing large data sets quickly to allow for data-informed decision-making. It also integrates different types of data to provide a more holistic view of the patient.

Juxly Timeline

  •  The company website can be found here.
  • Juxly Timeline's value proposition boasts an easily-customizable and interactive interface that displays a patient's EHR in a chronological view. The technology offers the ability to see the big-picture of a patient's diagnostic history while also organizing important details so they are easily accessible.


  • The platform website can be found here.
  • EvidenceCare is a direct competitor to Wellsheet because it sells the same type of product, has a similar revenue size, and also services the US.
  • Like Wellsheet, EvidenceCare sells a clinical decision support tool that is linked to EHR data and improves clinical workflow through assistive technology. Because Wellsheet self-describes as both a clinical decision and workflow support tool through its customizable interface, this distinction means Wellsheet provides a deeper level of support within the same kind of product, rather than offering a completely distinct product from EvidenceCare, resulting in a competitive edge.
  • With a revenue of $4.8 million, EvidenceCare competes in the same size range as Wellsheet. Estimates for Wellsheet's revenue range from $250,000 to $2.4 million.
  • EvidenceCare offers a clinical decision tool that is evidence-based, patient-focused, and boasts enhancements to workflow. It references a variety of data from partner institutions including American College of Emergency Physicians and EB Medicine.

Caden Clinical Decision

  • The website for Stanson Health's Caden CDS Cloud Engine can be found here.
  • Based in New Jersey, Caden CDS Cloud Engine (Caden) is a direct competitor to Wellsheet because they both sell the same type of product, fall within the same revenue range, and serve a US market. Like Wellsheet, Caden sells Clinical Decision Support (CDS), though it does not offer the same level of workflow support that Wellsheet offers its customers. Caden and Wellsheet fall in the same revenue range with revenues of $2.5 million and $250,000 to $2.4 million respectively.
  • Caden boasts a cloud engine that integrates EMR and provides CDS embedded right into the workflow through predictive technology and advanced algorithms.


  • HealthDecision's website can be found here. 
  • Because it sells the same type of product, falls within the same size range, and serves a US market, HealthDecision is a direct competitor to Wellsheet. HealthDecision also sells CDS tools that are personalized and user-friendly. It generates a revenue of $1.5 million which is close to Wellsheet's estimated range of $250,000 to $2.4 million.
  • HealthDecision offers a suite of CDS tools that personalize decision-making based on patient's EMRs and provides user-friendly interactive tools for more collaborative decision-making. Not only does it provide clinical care support, but the platform also provides data that can aid in billing, quality optimization, and insurance documentation.


  • The website for HealthReveal can be found here.
  •  Based in New York, HealthReveal is a direct competitor to Wellsheet because they both sell CDS technology, fall within the same size range, and serve a US clientele. Close to Wellsheet's estimated $250,000 to $2.4 million in revenue, HealthReveal generates $3 million in estimated revenue.
  • HealthReveal offers a CDS platform that is unique from its competitors in that it generates actionable interventions tailored to specific patients. The company's technology is AI-powered, evidence-based, precise, predictive, applies machine learning, and is also configurable to allow for clinician expertise.

Research Strategy

While UpToDate Pathways was also a direct competitor to Wellsheet because it sells CDS technology to a US market and generates $4.5 million in revenue, the research team did not explore further because we had already highlighted 6 competitors.

We were able to establish the other 6 companies as direct competitors and locate their value propositions through a direct search of company websites and business directories. A company is considered to be a direct competitor if they sell the same types of products or services, are in the same size range, and service the same general area. We were able to locate all of that information through the above-mentioned search.
of seven

Wellsheet - Competitors: Part One

Wellsheet is recognized federally for using its artificial intelligence to enhance providers EHR experience. But, other more notable competitors such as IBM's Watson and lesser known Juxly Timeline have experienced some success in the information customization field.

Watson's Competitive Advantages

Watson's Top Customers

  • Banner Health is an American hospital provider who employs an estimated 10,000 workers.
  • SSM Health is a US healthcare provider with over $1 billion in revenue and 10,000 employees.

Watson's Price

  • According to IBM Master inventor and senior consultant Tony Pearson, a Power 750 server cost around $34,500.
  • The 90 Power 750 servers that make up Watson cost about $3 million. That's just a little more expensive than a CT scan machine.
  • According to Finances Online, IBM Watson Analytics has a Plus pricing plan that starts at $30 a month, which allows you to analyze and visualize your data.

Watson's Services

  • Watson's cognitive services are being used in an array of products and services, ranging from navigation apps to personalized World Cup highlights.

Juxly Timeline's Competitive Advantages

  • According to Cerner Code, Juxly Timeline improves patient outcomes by quickly referencing the entirety of a patient's medical records.
  • Juxly has the ability to expand details, and filter results faster and easier.

Juxly Timeline's Customers

  • Dr. Louis Krenn, Chief Medical Information Officer at Cox Health says, "I use timeline to quickly and easily review patients records."

Juxly Timeline's Services

  • The service allows providers to view x-ray reports, procedure notes, and office visits.

Research Strategy

In an attempt to answer the clients questions fully and accurately several approaches were taken. The initial approach was to gather information pertaining to the advantages of the first two list of competitors. Once information on IBM Watson was collected the next step was to gather information on Juxly Timeline. Information on the second competitor what's more difficult and scarcely available. There was no available information pertaining to the price or cost of Juxly Timeline. Further attempts were made to register with pricing platforms, but the verification process would have taken too long to complete the request in a timely manner. There was little to no information referencing Juxly outside of the company's official website.
of seven

Wellsheet - Competitors: Part Two

Competitors: Part Two

The two competitors, EvidenceCare and Stanson Health, both offer patient-specific real-time solutions. However, their difference comes within the type of information offered. The former uses evidence-based solutions while the latter uses best practices. Additionally, while both companies can integrate their solutions with electronic health records (EHRs), EvidenceCare offers a platform for individual users, which can operate independently from EHRs.


  • Competitive advantage: EvidenceCare has a product differentiation competitive advantage. They provide a fluid and interactive platform wherein clinicians can access patient-specific and evidence-based treatment recommendations at the point of care in "as little as 30 seconds". Further, the provider version can operate independently without integration into a hospital's electronic health record workflow. According to GlobeNewswire, there are no other tools that can assist clinicians to make bedside decisions in this manner.
  • Top and targeted customers: Although the company is based in Nashville, Tennessee, the company targets hospitals and other healthcare providers in the U.S. They currently have over 5,000 users, including hospitals.
  • Publicly available pricing plans: Their Professional Plus solution for healthcare providers is $399 per year. Additionally, their core solution for healthcare providers is free. For hospitals, their solutions are tailor-made and prices are available after consultation.
  • Services offered: In addition to their real-time clinician decision support system, they offer patient education, integrated risk management, and Electronic Hospital Records (EHR) documentation.

Stanson Health

  • Competitive advantage: Stanson Health's Closed Loop Clinical Decision Support (CDS) platform also has a product differentiation competitive advantage. It is drawn from their unique combination of content management, their cloud CDS engine and their analytics, which enable them to provide real-time, patient-specific best practices at the point of care.
  • Publicly available pricing plans: Because this platform is particularly designed to work with organizational systems only, there are no price plans publicly available.
  • Services offered: In addition to the CDS platform, Stanson Health also offers different types of CDS analytics, including Alert Performance analytics for project teams, Provider Performance analytics for medical directors, and Impact analytics for senior leadership.

Research Strategy

Information regarding the uniqueness of the competitors' solutions are based on not only their descriptions of their products, but also from reports from independent media. Both companies have thousands of clients and the individual healthcare providers, and most of the hospitals, serviced are not significantly different in terms of size. Additionally, their clientele are not public records. As such, we have reasonably concluded that each of these companies do not have a single main client they service, which holds a significant share of revenue contributions.

of seven

Wellsheet - Competitors: Part Three

HealthDecision and HealthReveal are both early-stage companies working to assess patient risk, review treatment options, and lower cost-of-care. More information on each company, including services, customers, target customers, and competitive advantages, can be found below.


  • HealthDecision is a software platform that helps clinicians and patients assess the patient's risk for certain conditions and options for treatment, and then engage in shared decision-making.
  • HealthDecision offers tools for Atrial Fibrillation, Cardiovascular Risk, Osteoporosis, Breast Cancer Screening, Lung Cancer Screening, and Hypertension.
  • The competitive advantage of HealthDecision is that it was developed by clinicians, it integrates directly with the Electronic Health Record, it has patient-specific tools, and allows for visual documentation of the shared (patient & doctor) decision-making process.
  • Only one customer of HealthDecision, UW Health, was identified. However, upon further research it appears as if UW Health has ended their relationship with HealthDecision and moved to working with Healthwise.
  • In a press release by EBSCO Health announcing the acquisition of HealthDecision, it was stated that HealthDecision reaches "more than 26,000 patients a year".
  • The target customer of HealthDecision is most likely a large healthcare organization (hospital or group of clinicians) working in the areas of cardiovascular health, osteoporosis, hypertension and cancer screenings and utilizing electronic health records. Especially targeted will most likely be existing customers of EBSCO Health, as HealthDecision will be integrated into EBSCO Health's product line.
  • No information on pricing for HealthDecision or EBSCO Health products was found.
  • The lack of information on current customers or pricing plans may be due to the recent acquisition (Jan 2019) of HealthDecision by EBSCO Health, and that it is most likely still being integrated into EBSCO Health's product offerings.


  • HealthReveal uses AI to create a "digital twin of each patient" based on all medical data available (including health records, self-reported information and data from wearables). The system then suggests "Reveals", which are simply diagnostic and treatment suggestions specific to each patient. The Reveals are integrated into Electronic Health Records to work within clinicians already-established workflows.
  • By doing so, HealthReveal is able to "change the trajectory" of high-risk patients, thus providing them with earlier diagnosis, better treatment, and less expensive healthcare.
  • HealthReveal's competitive advantage is that it utilizes AI in order to generate actionable interventions tailored to specific patients.

Research Strategy

We were unable to find information on the current customers of HealthDecision, pricing information for HealthDecision, or pricing information for HealthReveal.

In order to find information on current customers of HealthDecision, we first began by reviewing the official website and resources of HealthDecision. In general, companies release some case studies, reviews, or success stories on their top customers, so we hoped to find that HealthDecision had released some of the same. While we found one mention of a single customer review (UW Health), and multiple success stories of other products by EBSCO Health (the parent company of HealthDecision), we were unable to find any specific case studies or other mentions of customers for HealthDecision.

We then conducted a general press search looking for press releases from healthcare practices announcing their work with HealthDecision. Generally, when large hospitals being working with a new company, they announce the partnership in a press release, so we were hoping to find some press releases announcing hospitals partnering with HelathDecision. However, this press search only returned the information that HealthDecision was recently acquired by EBSCO Health.

Finally, we reviewed the old website for HealthDecision, from when the company was a private company. We hoped to find mentions of customers utilizing HealthDecision before it was acquired by EBSCO Health, as we assumed these previous customers would continue as customers after the acquisition. However, we only found one company mentioned — UW Health — which we had already found previously mentioned on the current website of HealthDecisions.

Information on pricing for both HealthDecision and HealthReveal was not available. We first looked for this information in the company websites, hoping that each company would disclose pricing plans. However, while their websites provided ample information about the services of each company, no information on pricing was available.

Then, we moved to identifying current customers of each solution, to see if the news releases or case studies of current customers contained any information on pricing. However, for HealthDecision we were unable to find any current customers (see above). For HealthReveal, we were able to find a current pilot project, but did not find any information about pricing in the press release, or customer websites, of the pilot.

Finally, we did a general press search to see if any media about either company contained information on pricing. For HealthDecision, the only media we found was information about the acquisition of HealthDecision by EBSCO Health. While we found a few articles on HealthReveal, they did not contain pricing information, only information on recent partnerships with EmblemHealth and AdvantageCare Physicians as well as Civica.

We concluded that since each company is in an early phase, with HealthReveal just in the pilot phase and HealthDecision having just been acquired, pricing information may not be set by either company and may be on a case-by-case basis.
of seven

Wellsheet - Media Scan

Wellsheet has appeared in news media for contests, funding, and collaborations, among other things. Some news media articles are given below.

1. RWJBarnabas Health Funding

  • Wellsheet was funded by RWJBarnabas Health as Joseph Scott, executive vice president of health care transformation, mentioned in this news article.
  • The company (RWJBarnabas Health) funded and housed Wellsheet in their facility. This was a collaboration between Wellsheet, Cerner, and RWJBarnabas Health.
  • RWJBarnabas Health worked specifically with cardiology although Wellsheet also works with other specialties. They used this opportunity to enable cardiologists to save time and get directly to the information they need.

2. Health IT Finalist

  • Wellsheet was listed as one of the finalists in the health IT division at the MedCity INVEST conference.
  • The conference "brings together investors and executives from healthcare organizations with promising startups in the biopharma, diagnostics, medical device, health IT, and health services sectors."
  • The competition was called Pitch Perfect startup competition, which is one of the highlights of the conference.
  • The event was held at the Ritz Carlton hotel in Chicago on April 23rd and 24th this year.
  • The competition was judged by "Adam Koopersmith, a Partner with Pritzker Group Venture Capital; Jessica Zeaske, a partner with Echo Health Ventures; and Dr. John Mattison, CMIO and Assistant Medical Director, Kaiser Permanente."
  • The company was highlighted as a finalist in the "medical device track" category. Multiple health IT startups were listed as finalists including "technologies around physical therapy, improving access to care, predictive analytics and improving clinical workflows."

3. Craig Limoli

4. Innovations in Healthcare Technology Conference

  • Wellsheet was represented at the Innovations in Healthcare Technology Conference when some of their executives attended the conference as speakers and/or panelists.
  • The conference is held annually and this was the 8th episode.
  • The evolution of 3D technology was one of the topics of the conference apart from artificial intelligence and cybersecurity applications in healthcare.

5. BioAdvance Funding

6. Disrupt SF 2018

7. Seed Round

  • Wellsheet closed a seed round and added software engineering recruits to the team.
  • The company rolled out pilots at practices through Cerner and Athena Health.
  • These details were shared with the news agency by Craig Limoli, the CEO and co-founder of Wellsheet.
  • The seed round was valued at $800,000, which will be jointly funded by Real-Life Innovations, Newark Venture Partners, and BioAdvance.

8. Training and Funding with NVP

  • Newark Venture Partners selected 11 firms including Wellsheet for a training and funding program.
  • The firms were selected based on their market potential and their success.
  • The firms were offered a training program spanning 3 months. The program included seminars on business and technical subjects.
  • Newark Venture Partners "provides the young companies a minimum of $100,000 in cash, mentoring and at least a year of free communal work space, complete with gourmet kitchen, foosball and ping pong tables, and treadmill workstations, on the 7th floor of 1 Washington Park".

9. Demo Day

  • Wellsheet was one of the 11 companies that were listed as participating in the Demo Day offered by Newark Venture Partners.
  • The Demo Day was for NVP's Accelerator program. These companies showcased themselves at the Prudential Center for the day.

10. FHIR Health Data Aggregation App Contest

  • Wellsheet joined the winners of the provider experience challenge in the FHIR Health Data Aggregation App Contest offered by the Office of the National Coordinator.
  • The contest was an API-based app challenge offered by ONC in March 2016.

Research Strategy

We have compiled a list of 10 news media articles that mention Wellsheet, its founder, and/or its collaborations with other companies. We aimed at including the most recent news articles with preference given to those published during the past 24 months, however, we were only able to find 6 such articles. Therefore, we had to include some older articles as well. We implemented various strategies to find articles within the defined range without success. We firstly looked at news articles within the past 24 months and included those that we could find. Afterwards, we tried to find articles that mentioned either the company or its founder, Craig Limoli. This did not yield any helpful results either. We also tried to look for articles through industry news publications, e.g. the Boston Globe but we found that some of these sources were paywalled and we were unable to dig in for further information.

From Part 03
  • "Juxly Timeline integrates with your EHR to display a patient’s entire record in a unified chronological view. Quickly expand details, filter results, and easily find all of the data you need to enable the best possible health care outcome for your patient."
  • "The ability to gather and cross-analyze various data types can help improve outcomes and reduce costs with a more holistic understanding of patients."
  • "EvidenceCare accelerates providers’ clinical workflow by delivering guidance on the appropriate assessment, diagnostic, and therapeutic options for each patient."
  • "Predicting what clinicians need to know any specialty, any condition all within your EHR."
  • "Caden is integrated into key EMRs and can deliver CDS in the workflow, just like embedded content. But being in the cloud allows us to go beyond what’s possible inside the EMR. Whether using non-EMR data, performing complex calculations, or inferring additional patient facts through NLP, Caden gives content creators a new, robust set of tools to build the most effective CDS possible."
  • "The HealthDecision suite of clinical decision support tools streamline clinician-patient discussions regarding benefits and harms of medical options. It displays personalized guidelines and dynamically illustrates risk to support meaningful shared decision-making conversations at the point of care, all within the Cerner Millennium EHR workflow."
  • "Unlike the output from many of today’s predictive analytics and gaps in care tools, Reveals are actionable patient-specific diagnostic or therapeutic interventions. "
  • "Each Reveal considers hundreds of decision points and tens of thousands of data elements, dynamically anticipating and adjusting to changing health status, disease progression and co-illnesses."
From Part 05
  • "Unlike any other tool on the market, EvidenceCare provides clinicians with access to reliable, evidence-based treatment recommendations at the bedside in as little as 30 seconds."
  • "EvidenceCare’s network consists of more than 5,000 users, including hospitals, that layer the EvidenceCare CDS tool onto electronic health records (EHRs)"
  • "EvidenceCare is far more interactive and fluid than other programs. It allows providers to use both clinical judgment and validated decision tools."
  • "(CDS) tools that are integrated directly into the electronic health record (EHR) workflow, providing real-time, patient-specific best practices at the point of care. In addition, Stanson is also developing a prior authorization product that, once finalized, is expected to provide near real-time prior authorization decisions for medical and pharmacy benefits. This is expected to save providers and payers time and expense while enhancing patient and provider satisfaction."
  • "Unlike any other tool on the market, EvidenceCare provides clinicians with access to reliable, evidence-based treatment recommendations at the bedside in as little as 30 seconds. Designed by physicians and curated by leading physician experts and medical societies, patient-specific protocols are made available to healthcare providers via a web-based application with EHR integration that streamlines workflows. The company launched its enterprise version to hospitals in 2017."